Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine and pregabalin high-dose monotherapy versus combination therapy for postoperative pain after total knee arthroplasty
ChiCTR2400081990Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of duloxetine and pregabalin in postoperative pain and knee osteoarthritis (OA) (6 arms), sponsored by Xi'an Honghui Hospital. Primary endpoints: Brief Pain Inventory, Western Ontario and McMaster Universities Osteoarthritis Index and 1 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
duloxetinepregabalin
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400081990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081990.